SELLAS Life Sciences (SLS) Change in Inventory (2013 - 2015)
SELLAS Life Sciences (SLS) reported Change in Inventory of $789000.0 for Q2 2015, up 952.0% year-over-year from $75000.0 in Q2 2014, and up 4483.33% quarter-over-quarter from -$18000.0 in Q1 2015.
SELLAS Life Sciences (SLS) Change in Inventory (2013 - 2015) Analysis & Trends
SELLAS Life Sciences (SLS) has 3 years of Change in Inventory data on file, last reported at $789000.0 in Q2 2015.
- Change in Inventory for Q2 2015 came in at $789000.0, up 952.0% year-over-year; the trailing twelve-month figure through Jun 2015 was $993000.0 (up 1125.93% YoY), and the FY2014 annual result was $269000.0, down 30.31% from the prior year.
- Change in Inventory improved to $789000.0 in Q2 2015 per SLS's latest filing, from -$18000.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $789000.0 in Q2 2015 and troughed at -$39000.0 in Q4 2013.
- A 3-year average of $158444.4 and a median of $73000.0 in 2013 frame the typical range for Change in Inventory.
- The sharpest annual moves came in 2014 and 2015: Change in Inventory plunged 78.69% in 2014, then soared 952.0% in 2015.
- A 3-year view of Change in Inventory shows it stood at -$39000.0 in 2013, then jumped by 625.64% to $205000.0 in 2014, then soared by 284.88% to $789000.0 in 2015.
- Business Quant data shows SLS's Change in Inventory at $789000.0 in Q2 2015, -$18000.0 in Q1 2015, and $205000.0 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 51,468.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 97.70 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | SELLAS Life Sciences | 1.39 Bn | 1.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 789,000.00 |
| Jun 30, 2015 | 789,000.00 |
| Mar 31, 2015 | -18,000.00 |
| Mar 31, 2015 | -18,000.00 |
| Dec 31, 2014 | 205,000.00 |
| Dec 31, 2014 | 205,000.00 |
| Sep 30, 2014 | 17,000.00 |
| Sep 30, 2014 | 17,000.00 |
| Jun 30, 2014 | 75,000.00 |
| Jun 30, 2014 | 75,000.00 |
| Mar 31, 2014 | -28,000.00 |
| Mar 31, 2014 | -28,000.00 |
| Dec 31, 2013 | -39,000.00 |
| Dec 31, 2013 | -39,000.00 |
| Sep 30, 2013 | 73,000.00 |
| Sep 30, 2013 | 73,000.00 |
| Jun 30, 2013 | 352,000.00 |
| Jun 30, 2013 | 352,000.00 |